Grifols SA reported strong fourth-quarter results on February 26, 2025, with revenues of EUR 1,976 million and adjusted EBITDA of EUR 526 million, marking a 13.6% and 19% increase respectively. For the full year, revenue reached EUR 7,212 million, with a net profit of EUR 157 million, a 271% increase from 2023, largely driven by growth in Biopharma and efficient cash flow management.